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Abstract
Background
Environmental enteric dysfunction (EED) is widespread throughout the tropics and in chil-
dren is associated with stunting and other adverse health outcomes. One of the hallmarks of
EED is villus damage. In children with severe acute malnutrition (SAM) the severity of enter-
opathy is greater and short term mortality is high, but the metabolic consequences of enter-
opathy are unknown. Here, we characterize the urinary metabolic alterations associated
with villus health, classic enteropathy biomarkers and anthropometric measurements in
severely malnourished children in Zambia.
Methods/Principal findings
We analysed 20 hospitalised children with acute malnutrition aged 6 to 23 months in Zam-
bia. Small intestinal biopsies were assessed histologically (n = 15), anthropometric and gut
function measurements were collected and the metabolic phenotypes were characterized
by 1H nuclear magnetic resonance (NMR) spectroscopy.
Endoscopy could not be performed on community controls children. Growth parameters
were inversely correlated with enteropathy biomarkers (p = 0.011) and parameters of villus
health were inversely correlated with translocation and permeability biomarkers (p = 0.000
and p = 0.015). Shorter villus height was associated with reduced abundance of metabolites
related to gut microbial metabolism, energy and muscle metabolism (p = 0.034). Villus blunt-
ing was also related to increased sucrose excretion (p = 0.013).
Conclusions/Significance
Intestinal villus blunting is associated with several metabolic perturbations in hospital-
ized children with severe undernutrition. Such alterations include altered muscle
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metabolism, reinforcing the link between EED and growth faltering, and a disruption
in the biochemical exchange between the gut microbiota and host. These findings
extend our understanding on the downstream consequences of villus blunting and
provide novel non-invasive biomarkers of enteropathy dysfunction. The major limita-
tions of this study are the lack of comparative control group and gut microbiota char-
acterization.
Introduction
Nutritional disorders are glaring examples of health inequalities between high- and low-
income countries, and within low-income countries. Malnutrition underlies almost half of all
child deaths globally and contributes enormously to the unacceptably high under-5 mortality
rates in many countries [1]. Chronic undernutrition is usually manifested as stunting (poor
linear growth), affects 30–40% of children in Zambia [2], and is associated with increased mor-
tality [3], reduced neurodevelopmental potential and decreased long-term economic produc-
tivity [4]. Chronic undernutrition can also result in severe enteropathy (environmental enteric
dysfunction), which includes alterations to intestinal cell morphology, gut barrier disruption,
and nutrient malabsorption. Another consequence of enteropathy is increased susceptibility to
pathogenic infections, and poor response to oral vaccines and nutritional interventions. Acute
malnutrition is usually manifest as wasting (loss of tissue), and severe acute malnutrition
(SAM) carries the highest mortality [5], particularly if associated with complications. HIV has
changed the epidemiology, pathogenesis and clinical presentation of SAM, and children with
both conditions have a particularly high mortality [6]. Over the last two decades, developments
in the approach to treatment such as standardized management protocols and ready to use
therapeutic food (RUTF) have improved the outcome of SAM [7,8]. However, children with
clinical complications of SAM requiring hospital treatment [9] often fail to respond to treat-
ment [10], and continue to experience high mortality of up to 35% [5,11]. In our experience it
is a subgroup of children with SAM and persistent diarrhoea who pose the most difficult man-
agement challenges, although the vast majority of children with SAM have a degree of enterop-
athy [11–13]. Currently, there is no perfect non-invasive biomarker for the diagnosis of
enteropathy and there is a pressing need to greater understand the biochemical perturbations
associated with enteropathy associated with SAM and diarrhea so that novel therapies can be
devised and tested.
Metabolic profiling is a systems biology approach that simultaneously measures a com-
prehensive range of metabolites within a biological sample to capture the metabolic pheno-
type of the biological system. We have recently demonstrated the utility of studying the
urinary metabolic phenotypes of children and rodents to understand the biochemical
impact of malnutrition and stunting in children and rodents [14,15]. This allows the bio-
molecular mechanisms of developmental shortfalls to be studied as well as the elucidation
of biomarkers to identify susceptible individuals. Importantly, metabolic profiles are the
product of genetic and environmental factors, providing information on the interactions
between the genotype, the diet, lifestyle, and gut microbiota. We postulated that a meta-
bolic phenotyping approach may provide molecular insights into EED, so we set out to
determine if 1H nuclear magnetic resonance (NMR) spectroscopy-based metabolic profil-
ing approach could describe any of several facets of the EED disorder and find new EED
biomarkers correlated with gut function.
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Methods
Study patients
We studied children with persistent diarrhoea (three or more loose stools per day for 14 days
or more) and severe acute malnutrition (SAM) in the malnutrition ward of the University
Teaching Hospital, Lusaka, Zambia, which has been the setting for several previous studies
[11,16]. In total, 20 children with SAM in hospital were studied. They were consecutive admis-
sions to the ward where the inclusion criteria were fulfilled. SAM was defined as WLZ < -3 or
MUAC < 11.5 cm or bilateral oedema. These children were severely malnourished but with
no pathogen detected on first line investigations (stool microscopy and culture). In total 67%
of the children has Kwashiorkor. Their management closely followed WHO guidelines [9]
with standardised treatment protocols and universal administration of antibiotics and oral
rehydration therapy. All children in the SAM group were receiving F100 milk-based formula
in the few days leading up to the day of collection of these samples.
Ethics statement
Children were recruited once stabilised, after the initial treatment phase when mortality is
highest, by approaching the mother and following discussion with the whole family. A parent
or guardian provided written informed consent on behalf of child participants. Approval to
study these children was obtained from the University of Zambia Biomedical Research Ethics
Committee (number 006-01-13, dated 15th April 2013).
Anthropometry
Length and weight were measured using a length board (Seca) and mother-and-child weighing
scales. Mid upper arm circumference (MUAC) was measured in accordance with WHO stan-
dard protocols.
Blood biomarkers
Following a three hour fast, blood (taken with 4% tetracaine topical anaesthesia) and urine
samples were collected. Blood samples were collected into EDTA, plain and lithium heparin
tubes (Vacutainer, Becton Dickinson, Plymouth, UK) and one additional lithium heparin tube
(TekLab) for trace element analysis. Blood samples were kept in the dark for 20 minutes then
centrifuged at 537 g for 15 minutes; serum was then aliquoted into 1.5 mL tubes for storage at
-80˚C. Quantification of lipopolysaccharide (LPS) was by the Pyrochrome Limulus Amoebo-
cyte Lysate (LAL) assay (Associates of Cape Cod, Liverpool, UK). Serum Insulin like growth
factor (IGF) 1, IGF binding protein 3 (IGFBP-3), LPS binding protein (LBP), soluble cluster of
differentiation 14 (sCD14), cluster of differentiation 163 (CD163), fatty acid binding protein
(FABP), and C reactive protein (CRP) were measured by ELISA (R&D systems, Abingdon,
UK). GLP2 was measured by ELISA (Millipore, Watford, UK).
Endoscopy and small intestinal biopsy
Endoscopy was carried out in a subsample of the study (n = 15) under sedation by an anaesthe-
tist, using a Pentax EG-2490i paediatric gastroscope. Gastric acid was aspirated by syringe and
pH tested using indicator paper (Sigma, Poole, UK) to within 0.5 pH units. Three biopsies
were collected from the second part of the duodenum, and placed into saline prior to orienta-
tion under a dissecting microscope and fixation on cellulose acetate paper in formalin-saline.
Morphometric parameters included measures of villus and crypt remodeling as reported in
several previous studies [17–21]. Villus blunting is associated with reduced villus height,
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increased villus width, reduced villus epithelial surface, and increased villus compartment vol-
ume. Morphometry was carried out on digitized images of well-orientated biopsies, and mea-
sures of villus height (VH), villus width (VW), villus perimeter (VP), crypt depth (CD), and
surface area:volume ratio obtained as previously described [19, 20]. At least six villus crypt
units were measured in each case.
Absorption and permeability testing
A test solution containing 0.2 g rhamnose, 1 g lactulose per dose (50 mL) was instilled directly
into the duodenum at the end of the endoscopy, as previously described [19]. The median
time to urine collection was 123 minutes (IQR 75–221) with a range from 34 to 314 minutes.
1H NMR spectroscopic analysis
Urine samples were collected from children prior to endoscopy, and immediately decanted into
a container with 1 mL 0.5% chlorhexidine. These samples were stored at -80˚C until transporta-
tion to London on dry ice. Urine samples (400 μL) were combined with 200 μL of phosphate
buffer (pH 7.4; 100% D2O) containing 1 mM of 3-trimethylsilyl-1-[2,2,3,3-
2H4] propionate
(TSP) as an external standard and 2 mM sodium azide as a bacteriocide. Samples were mixed
by vortexing and centrifugated at 10000 g for 10 minutes. The supernatant (550 μL) was trans-
ferred to a 5 mm internal diameter NMR tube. The metabolic profiles of the urine samples were
measured by 1H nuclear magnetic resonance (NMR) spectroscopy using a 700 MHz Bruker
NMR spectrometer operating at 300 K. For each urine sample a standard noesy experiment was
performed with water-suppression using 8 dummy scans followed by 128 scans collected into
64K data points. A mixing time of 10 ms was used with an acquisition time of 3.8 s and a recycle
delay of 3.0 s.
1H NMR spectra were manually corrected for phase and baseline distortions. Chemical
shifts in the spectra were referenced to the TSP peak at δ 0.0 ppm. Spectra were digitized using
an in-house Matlab (version R2012a, The Mathworks, Inc.; Natwick, MA) script. Resonances
derived from water were removed to minimize distortions to the spectral baseline. Spectra
were normalized to the total area.
Statistical analysis
Normality of continuous variables was assessed by normal probability plots. Non-normally
distributed variables were log transformed if necessary. Pearson correlation analyses were
used to evaluate relationships among variables. The significance level of the correlations was
adjusted to p<0.017. This value of significance threshold (p = 0.017) (α) has been obtained by
dividing the nominal significance threshold for a single test (c) by the number of effectively
independent tests (n): α = c/n = 0.05/3 = 0.017. For the calculation of the n = 3 we used the
hierarchical cluster analysis which was able to classify the 17 variables into three independent
groups of biomarkers (gut function and inflammation, growth, and villus morphometry) (Fig
1). This method was adapted from Cheverud JM et al (2001) and is based on the variance and
dissimilarity of the variables [22]. Furthermore, hierarchical clustering was used to order the
variables and identify hidden structure within the data. Univariate statistical analyses were per-
formed by SPSS 18.0 software (IBN Corp) and cluster/correlation analyses by R 3.2.1 (The R
project).
Orthogonal projection to latent structures (OPLS) analysis with unit variance scaling was
used to study the 1H NMR spectral profiles. Here, the metabolic profiles served as the descrip-
tor (X) matrix and villus height (or classical measurements of gut health) was the response (Y)
vector. The predictive ability of the model (Q2Y) was calculated using a seven-fold cross
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validation approach and its significance was determined by permutation testing (1000 permu-
tations). Statistical analyses related to metabolomics were performed using an in-house Matlab
(version R2012a, The Mathworks, Inc.; Natwick, MA) script.
Results
Anthropometry and growth factors biomarkers
Outliers were detected from the Box-plots in MUAC and FABP variables and eliminated from
future analysis. These studied children were severely stunted (LAZ: mean = -3.06 ± 1.49),
severely underweight (WAZ: mean = -3.49 ± 1.58), and moderately wasted (WLZ: mean =
-2.68 ± 1.58) (Table 1). Correlation analysis found a direct association between IGF-1 and
Fig 1. Correlodendogram with pearson correlations among bacterial translocation, intestinal permeability, villus
structure, metabolites, and growth variables. Color intensity and size of the circle are proportional to the correlation
coefficients. Significant correlations are shown following correction for multiple testing. FABP, fatty acid binding
protein; LAZ, length-for-age Z score; IGF-1, insulin like growth factor 1; IGFBP-3, insulin like growth factor binding
protein 3; LPS, lipopolysaccharide; LBP, lipopolysaccharide binding protein; MUAC, mid-upper arm circumference;
VH, villus height; VPMM, villus perimeter or epithelial surface area; VW, villus weight; WAZ, weight-for-age Z score;
WLZ, weight-for-length Z score.
https://doi.org/10.1371/journal.pone.0192092.g001
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IGFBP-3 (r = 0.656; p = 0.011). IGF-1 was positively correlated with MUAC, and weight-for-
height Z (WLZ) score (r = 0.789; p = 0.002; r = 0.654; p = 0.011, respectively) (Fig 1).
Measures of gut health
Mucosal morphometry showed clear evidence of enteropathy with villus blunting and greatly
increased inflammatory infiltrate (Fig 2) compared to literature controls (S1 Table). Measures
of gut health also indicated villus blunting in the children studied (villus height (VH) mean =
197.94 ± 65.58 μm; villus perimeter (VP) mean = 451.65 ± 196.05 μm, Table 1) and villus infl-
ammation (villus width (VW) median = 148.01 (128.55; 282.12) μm). Gut permeability was
determined in the study children by measuring the lactulose:rhamnose ratio (LR; mean 0.38 ±
0.36) in urine and gut microbial translocation was evaluated by measuring serum LPS binding
protein (LBP) (mean = 219.37 ± 107.71 μg/mL).
Correlation analysis revealed statistical associations between several villus morphometry
parameters and measures of gut function (Fig 1). VH and VP were positively correlated
(r = 0.67; p = 0.007) as were LR and LBP (r = 0.73; p = 0.016). An inverse relationship was seen
between the LR and VP (r = -0.95; p = 0.000) and LR and VH (r = -0.81; p = 0.015). LBP was
positively associated with VW (r = 0.73; p = 0.016). Furthermore, fatty acid binding protein
(FABP) was negatively correlated with MUAC (r = -0.73; p = 0.011).
Table 1. Characteristics of the participants.
Undernourished hospitalized childrena (n = 20)b
GENERAL AND ANTHROPOMETRICS
Sex: male 11 (55%)
Age (months) 15.45 ± 5.42
HIV: positive 8 (40%)
Mid-upper arm circumference (MUAC) (cm) 11.14 ± 1.11
Height for Age Z score (LAZ) -3.06 ± 1.49
Weight for Age Z score (WAZ) -3.49 ± 1.58
Weight for Height Z score (WLZ) -2.68 ± 1.58
Insulin like growth factor 1 (IGF-1) (ng/mL) 9.89 (9.25;14.28)
Insulin like growth factor binding protein 3 (IGFBP-3)
(ng/mL)
736.74 ± 471.65
ENTHEROPATIC AND PERMEABILITY BIOMARKERS
Lactulose/Rhamnose ratio (L/R) 0.38 ± 0.36
Lipopolysaccharide (LPS) (EU/mL) 522.72 ± 594.88
LPS binding protein (LBP) (ng/mL) 219.37 ± 107.71
Glucagon-like peptide 2 (GLP-2) (ng/mL) 2.75 ± 2.06
Fatty acid binding protein (FABP) (pg/mL) 2938.19 ± 1409.89
CD163 (ng/mL) 1421.57 ± 843.26
SCD14 (ng/mL) 2794.97 ± 1272.28
C reactive protein (CRP) (ng/mL) 3950.15 ± 5931.50
GUT BIOPSY PARAMETERS
Villus height (VH) (μm) 197.94 ± 65.58
Villus width (VW) (μm) 148.01 (128.55;282.12)
Crypt depth (CD) (μm) 169.32 ± 31.91
Villus perimeter (VP) (μm) 451.65 ± 196.05
a) Values expressed as mean ± S.D. or median (25th to 75th percentile).
b) The sample size for gut biopsy parameters was 15.
https://doi.org/10.1371/journal.pone.0192092.t001
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Non-significant correlations were observed among CD14, CD163, CRP, gastric pH, GLP2,
and LPS variables neither with other parameters.
Urine metabolic signatures associated with villus height
An outlier was detected from the PCA analysis and eliminated from future analyses. A signifi-
cant OPLS model was obtained identifying metabolic variation associated with VH
(Q2Y = 0.303; p = 0.034). Metabolites found to be significantly correlated with VH in this
model are visualized in a clustergram in Fig 3. Here, the z-scores of the peak integrals for the
metabolites are plotted for each child along with the correlation coefficients extracted from the
OPLS model. Metabolites related to gut microbial metabolism were excreted in lower amounts
by individuals with shorter VH. This included 2−hydroxyisobutyrate (2-HIB), 4
−hydroxyphenylacetate (4-HPA), phenylacetylglutamine (PAG), 3−indoxyl sulfate (3-IS), acet-
amide, 4−hydroxyhippurate (4-HH), and microbial metabolites of choline (dimethylamine
(DMA), trimethylamine (TMA)). Metabolites related to energy and muscle metabolism (succi-
nate, creatinine, β-hydroxy-β-methylbutyrate (HMB)) were also excreted in lower amounts by
children with blunted villi (shorter VH) as were tyrosine, pseudouridine, and N-acetyl-glyco-
protein (NAG). Increased excretion of sucrose was associated with villus blunting although
this was driven by the large excretion of sucrose by two individuals with the shortest villi.
Additional OPLS models were built using the other measures of gut health and classical mea-
sures of EED and growth as the response vector, however, no other significant OPLS models
were obtained (S2 Table).
As markers of muscle mass, creatinine and HMB, were correlated with other measures of
growth and gut health and function (Fig 1). Creatinine and HMB were positively correlated
with each other (r = 0.55; p = 0.016). HMB was positively correlated with VH (r = 0.64;
p = 0.013). Creatinine was also positively correlated to VH reaching a borderline significance
(r = 0.61; p = 0.022). Interestingly, creatinine and HMB were found to cluster with villus health
parameters (VH and VP). In addition, sucrose was found to cluster with measures of impaired
intestinal barrier function. Furthermore, sucrose was positively correlated with LR, LBP, and
VW, and negatively correlated with VH and VP (r> 0.67; p< 0.017) (r = -0.64; p<0.017).
Discussion
The lack of significant progress in reducing mortality in the most severely ill children with
SAM and intestinal disease over the last few decades requires fresh approaches. Here we report
a study of the metabolome in 20 hospitalized children with SAM and diarrhoea, in our experi-
ence the group with the worst outcome, in order to identify urinary and plasma biomarkers of
enteropathy. An integrated multi-tier approach was used combining morphological assess-
ments of gut health using intestinal biopsy samples with anthropometric and biochemical
Fig 2. Mucosal abnormalities in biopsies from hospitalized children. The biopsies showed a range of abnormalities
including (A) moderate villus blunting or (B) total villus atrophy.
https://doi.org/10.1371/journal.pone.0192092.g002
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Fig 3. Dendogram and heatmap representation of unsupervised hierarchical clustering (HCA) of the metabonome for all children sorted according to the villus
height (VH). Each column corresponds to a single children and each row corresponds to a specific metabolites. Only metabolites identified to correlate with VH
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measures of gut function, growth and metabolic status. We have identified signatures of dis-
turbed metabolism of the gut microbiota, notably choline metabolism, and reduction of several
specific host metabolic pathways including energy and muscle metabolism as well as tyrosine,
pseudouridine, and N-acetyl glycoprotein. In contrast, sucrose excretion was increased with
villus blunting.
Environmental enteric dysfunction arises from a vicious cycle of undernutrition and enteric
infections. It is characterized by villus blunting, loss of barrier function (leaky gut), and malab-
sorption and has been implicated in growth stunting and cognitive impairments [23,24]. Intesti-
nal biopsies collected in this study indicated that all children studied exhibited severe enteropathy
with blunted villi (VH: 197.94 ± 65.58 μmm), severe enteric dysfunction (L/R ratio: 0.38 ± 0.36,
LBP: 219.37 ± 107.71 μg/mL) and inflammation (CRP: 3950.15 ± 5931.50 ng/mL). Reductions in
epithelial surface area, measured as VP, have been previously observed in Zambian adults with
EED [20], and we found evidence that this could be an adaptation process to reduce microbial
translocation.
Correlation analysis identified a statistical relationship between altered morphological
structure and disrupted function with an inverse correlation between VH (positive correlation
with villus blunting) and small intestinal permeability (LR ratio). VW, another parameter asso-
ciated with villus blunting, showed a positive correlation with LBP linking villus atrophy with
bacterial translocation. LBP, LR, and LPS in our studied children with SAM were higher than
in community children who were not acutely malnourished [21]. Furthermore, in the studied
children, LPS was two orders of magnitude higher than in Italian children with fatty liver dis-
ease [25] and higher than in adults with EED [20]. As well as functional consequences associ-
ated with morphological changes in the gut several markers of gut health/function were also
associated with growth. FABP, a marker of enterocyte death and gut barrier disruption, was
negatively correlated with MUAC, a key measure of growth. Similar observations have been
reported in a cohort of community children with EED in Brazil [26]. As expected, MUAC was
positively associated with other measures of growth (WAZ, WLZ) and promoters of growth
(IGF-1).
Metabolic phenotyping was applied to characterize the urinary metabolic profiles of these
children to better understand the biochemical mechanisms underlying growth shortfalls
resulting from impaired gut health. Using a high-resolution untargeted 1H NMR spectroscopy
based approach we found numerous urinary metabolites strongly correlated with villus height
which is currently the gold standard for defining enteropathy. Villus blunting was associated
with a lower excretion of creatinine and HMB, metabolites related to muscle metabolism and
anabolism, indicating that muscle mass is reduced with villus blunting. Consistent with this
observation, we have recently reported a reduction in creatinine excretion in undernourished
Brazilian children with impaired growth [15]. HMB is a metabolite of leucine and reduced
excretion of HMB with blunted villi may reflect impaired uptake of this branched chain amino
acid from the diet. Muscle loss results from an imbalance between muscle protein synthesis
and muscle protein degradation. HMB has been found to stimulate muscle protein synthesis
through the mTOR-p70S6K1 pathway [27]. Moreover, the ubiquitin-proteasome proteolytic
pathway is responsible for increased protein degradation in many disorders and can be
induced by the pro-inflammatory cytokine tumor necrosis factor- α (TNF-α) following LPS
through and OPLS model were used for metabolite clustering. Metabolite z-score transformation was performed on the levels of each metabolite across samples, with
blue denotating a lower and red a higher level compared to the mean. Metabolites were clustered using correlation distance and average linkage. DMA, dimethylamine;
2-HIB, 2−hydroxyisobutyrate; 4-HPP, 4-hydroxypurate; 4-HPA, 4-hydroxyphenylacetate; 3-IS, 3−indoxyl sulfate; NAG, N-acetylglycoprotein; PAG,
phenylacetylglutamine; TMA, trimethylamine.
https://doi.org/10.1371/journal.pone.0192092.g003
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exposure. Interestingly, HMB has been shown to attenuate the increase in protein degradation
induced by TNF-α [28]. Furthermore, when given in combination with L-arginine and L-glu-
tamine, HMB has been demonstrated to prevent lean tissue loss in patients with AIDS-associ-
ated wasting [29]. As such, further work is required to greater understand the multiple factors
driving muscle loss with SAM and to evaluate the potential for HMB or leucine supplementa-
tion to ameliorate such effects.
In this study, urinary excretion of sucrose was associated with a shorter villus height. The
two children with the most blunted villi drove these observations although comparisons with
healthy children are not possible. In health, sucrose is derived from the diet and is hydrolyzed
by sucrase in the brush border to glucose and fructose. In our unit, children with SAM are
treated with standard nutritional rehabilitation which includes formula feeds containing
sucrose. Increased sucrose excretion with blunted villi suggests that urinary sucrose is not suf-
ficiently broken down when the mucosa is damaged and that paracellular absorption occurs
following a loss of barrier function. This is supported by the positive correlation between
sucrose excretion and LBP and LR. Sucrose excretion could be used as a diagnostic test to eval-
uate barrier function without the need for prior consumption of test sugars (e.g. lactulose,
rhamnose, mannitol). However, further work is required to evaluate the mucosal damage
threshold at which sucrose is absorbed. Previous studies by other groups discounted the
sucrose permeation test as a test of small intestinal permeability [30–32], but sucrose excretion
in urine may reflect the more extreme enteropathy in SAM.
Reductions in epithelial surface area seen in these children have been previously observed
in Zambian adults with EED. This might represent an adaptive response to reduce microbial
translocation [20]. Although the composition or abundance of the gut microbiota has not been
measured in these children, our approach does enable to functional state of the microbiome to
be characterized. Villus blunting was associated with a reduced excretion of gut bacterial-host
co-metabolites. This included a range of metabolites derived from the bacterial breakdown of
amino acids including tryptophan (3-IS, acetamide), phenylalanine (PAG, 4-hydroxyphenyla-
cetate), as well as bacterial metabolism of polyphenols (4-hydroxyhippurate), choline (DMA,
TMA), and carbohydrates (2-hydroxyisobutyrate). A reduction in epithelial surface area, or a
change in the abundance or composition of mucins, would decrease availability of binding
sites for community assembly. It is feasible that this may reduce or modify the microbial popu-
lations present in the gut and reduce the flow of microbial products to the host. In agreement
with this, compositional and functional variation in the gut microbiota has been previously
observed with undernutrition in rodent and human studies [14,33,34,35]. However, the
reduced excretion of microbial-derived metabolites observed with villus blunting may also be
driven by reduced uptake of microbial products due to malabsorption. As such, further studies
are necessary to characterize the gut microbial changes associated specifically with villus blunt-
ing to clarify this observation.
No gold standard biomarker for EED currently exists and an invasive gut biopsy is required
for a definitive diagnosis. In this study, we have combined intimate measures of gut health
with information-rich metabolic phenotypes to illuminate novel urinary biomarkers indicative
of specific gut damage. To this effect, several biomolecular features were discovered to be asso-
ciated with villus height. This panel of non-invasive biomarkers included metabolites from
endogenous and exogenous sources and warrant further exploration. A major limitation of
this work is the lack of a comparative control group studying children from the same setting
with a healthy gut. However, as an endoscopy could not be performed on community control
children this was not possible. In addition, due to the intensive and time-consuming nature of
the procedure used the sample size was relatively small. While a larger sample size may have
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yielded additional biomarkers of gut health, the detection of the current biomarkers in this
smaller group indicates the significance of their relationship with villus height.
Conclusions
To the best of our knowledge, this is the first time that morphological assessments of gut health
have been correlated with non-invasive measures of growth, gut health and metabolic status.
These findings imply that structural alterations induced by the chronic cycle of undernutrition
and infection impact on the functioning of the gut with a downstream impact on protein syn-
thesis, muscle development, and ultimately growth. Furthermore, modifications to the villus
environment also modulate the important relationship between the intestinal microbiota and
the host. These finding brings new knowledge to EED and may lead to non-invasive biomark-
ers of enteropathy.
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